Alireza Faridar, MD

Projects

Projects per year 2016 2016 2019 2021 2024 2031

• 2 Finished
• 20 Active

Projects per year

Search results

• Active

  Multi-omic integrative analysis of shared and distinct inflammation networks across neurodegenerative disorders

  Faridar, A. (PI)

  9/30/24 → 8/31/25

  Project: Federal Funding Agencies

• A Phase I Clinical Trial, Using Interleukin-2 (IL-2) and Abatacept in Patients with Frontotemporal Disorders

  Faridar, A. (PI), Appel, S. H. (Key Personnel), Masdeu, J. C. (Key Personnel) & Pascual, B. (Key Personnel)

  6/10/24 → …

  Project: Clinical Trial

• Biomarker in Aging-Related Disorders (BARD)

  Toledo, J. B. (PI), Faridar, A. (Key Personnel), Masdeu, J. C. (Key Personnel) & Pascual, B. (Key Personnel)

  4/23/24 → …

  Project: Clinical Trial

• Central and peripheral immune cross-talk in Alzheimer's disease and their modulation by a novel immunotherapy

  Faridar, A. (PI)

  1/1/23 → 12/31/25

  Project: Federal Funding Agencies

• Imaging for Precision Medicine in Alzheimer's Disease and Related Disorders

  Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Karmonik, C. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel) & Roman, G. C. (Key Personnel)

  5/25/22 → …

  Project: Clinical Trial

• New IDEAS: Imaging Dementia¿Evidence for Amyloid Scanning StudyA Study to Improve Precision in Amyloid PET Coverage and Patient Care

  Masdeu, J. C. (PI), Faridar, A. (CoI), Nakawah, M. O. (CoI), Pascual, B. (CoI) & Roman, G. C. (CoI)

  11/18/21 → 11/17/31

  Project: Non Profit

• Tregs in AD clinical trial A Phase II Clinical Trial of Interleukin-2 (IL-2) in Patients with Mild to Moderate Alzheimer's Disease Progress

  Faridar, A. (PI), Masdeu, J. C. (Key Personnel) & Pascual, B. (Key Personnel)

  9/9/21 → …

  Project: Clinical Trial

• Regulatory T cells as a novel therapeutic target in Alzheimer's Disease

  Appel, S. H. (PI), Faridar, A. (PI) & Masdeu, J. C. (PI)

  8/1/21 → 6/30/25

  Project: Non Profit

• Houston Alzheimer Disease Study

  Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Karmonik, C. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel), Roman, G. C. (Key Personnel), Toledo, J. B. (Key Personnel) & Wong, S. T. (Key Personnel)

  5/17/21 → …

  Project: Clinical Trial

• A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

  Toledo, J. B. (PI), Faridar, A. (Key Personnel), Masdeu, J. C. (Key Personnel), Nakawah, M. O. (Key Personnel) & Pascual, B. (Key Personnel)

  3/12/21 → …

  Project: Clinical Trial

• Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of AL001 in FTD (AL001-3) (INFRONT-3)

  Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Pascual, B. (Key Personnel) & Toledo, J. B. (Key Personnel)

  10/20/20 → …

  Project: Clinical Trial

• Ocrelizumab for Psychosis by Autoimmunity (OPA)

  Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Madan, A. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel), Toledo, J. B. (Key Personnel) & Weinstein, B. (Key Personnel)

  2/20/20 → …

  Project: Clinical Trial

• 18F-MK-6240 Tau PET and Brain Inflammation in Alzheimer’s Disease

  Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel) & Roman, G. C. (Key Personnel)

  10/29/19 → …

  Project: Clinical Trial

• AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial)

  Masdeu, J. C. (PI), Toledo, J. B. (PI), Faridar, A. (CoI) & Nakawah, M. O. (CoI)

  9/30/19 → 5/31/25

  Project: Federal Funding Agencies

• ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

  Pascual, B. (PI), Faridar, A. (CoI) & Masdeu, J. C. (CoI)

  9/15/19 → 6/30/25

  Project: Non Profit

• Role of Brain Inflammation in Alzheimer’s Disease

  Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Nakawah, M. O. (Key Personnel) & Pascual, B. (Key Personnel)

  2/7/18 → …

  Project: Clinical Trial

• LONGITUDINAL EARLY ONSET ALZHEIMERâ??S DISEASE (LEADS)

  Masdeu, J. C. (PI), Faridar, A. (CoI), Nakawah, M. O. (CoI) & Pascual, B. (CoI)

  9/15/17 → 5/31/25

  Project: Non Profit

• NMDA Receptor in Psychosis: Specific Auto-Antibodies

  Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel) & Toledo, J. B. (Key Personnel)

  11/14/16 → …

  Project: Clinical Trial

• Neuroimaging in AD

  Masdeu, J. C. (PI), Faridar, A. (Key Personnel), Karmonik, C. (Key Personnel), Nakawah, M. O. (Key Personnel), Pascual, B. (Key Personnel), Roman, G. C. (Key Personnel) & Toledo, J. B. (Key Personnel)

  9/15/16 → …

  Project: Clinical Trial

• PBR28 PET

  Masdeu, J. C. (PI), Appel, S. H. (Key Personnel), Faridar, A. (Key Personnel), Karmonik, C. (Key Personnel), Nakawah, M. O. (Key Personnel) & Pascual, B. (Key Personnel)

  6/7/16 → …

  Project: Clinical Trial

• Finished

  Characterizing Adaptive Immune Mechanism in Alzheimer: a Key to Therapy

  Faridar, A. (PI)

  7/1/19 → 8/30/21

  Project: Non Profit

• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subjects With Preclinical Alzheimer¿s Disease and Elevated Amyloid (A45 Trial) and in Subjects With Early Preclinical Alzheimer¿s Disease and Inter Amyloid (A3 Trial)

  Masdeu, J. C. (PI), Toledo, J. B. (PI), Faridar, A. (CoI) & Nakawah, M. O. (CoI)

  6/1/19 → 4/30/24

  Project: Federal Funding Agencies